Jessica Hagen

The vision-restoring device will be implanted in humans within six to 12 months, following a successful monkey implantation that has remained active for three years, Musk said.

Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.

The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year. 

In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.

Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.

The partnership will allow Oura Ring wearers to share their biometric data with the virtual women's health company's care teams.

The company's valuation has increased by $1 billion since its $130 million Series E funding round last year.

Nissan Elimelech, founder of Augmedics, discusses the process of developing augmented reality surgical navigation technology and his next endeavor to develop the first AR glasses specifically for healthcare.

Wojcicki, cofounder and former CEO of 23andMe, is set to reacquire the company through her nonprofit, TTAM Research Institute.

A global outage on Thursday disrupted a range of services, including several AI tools widely used in healthcare, such as Vertex AI, Dialogflow CX, Agent Assist and Contact Center AI.